Skip to main content

Menlo Park cancer-screening unicorn Grail files plan to go public

Grail, founded by gene sequencing company Illumina Inc. in 2016, has raised about $2 billion in funding from investors that include Bezos Expeditions, the venture investment fund of Jeff Bezos.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.